The death of George Floyd has accelerated calls for police reform. Although decriminalizing drugs and the people who use them will not end police …
The collective trauma of the Covid-19 pandemic may provide a clearer understanding of why people use drugs — to help us see it not …
The authors examine recent trends in vaping, research on its effectiveness for smoking cessation, the role of industry marketing and policy responses to increased …
By Katharine Neill Harris and Jay Jenkins The authors use survey and interview data to evaluate drug treatment options available through the court diversion …
Fellow Katharine Neill Harris considers the validity of risk assessment tools, which estimate the likelihood that an individual who has been charged with or …
In recent years public opinion surveys have found that a consistent and increasing percentage of Texans support marijuana reform, but this support has not …
By providing regulated and safe access to medical cannabis to people with demonstrated need, the Texas Legislature can provide justified relief, help reduce the …
Increasing funding for drug treatment programs in prison may help reduce the opioid epidemic, according to an op-ed authored by Katharine Neill Harris, the …
Drug Policy Program director Bill Martin summarizes the scientific and fiscal evidence supporting the efficacy of syringe exchange programs and outlines a framework for …
Using charts, figures and graphs of this survey data originally created by former career intelligence analyst Brian C. Bennett and updated by the Drug …
Policy regarding drugs, both legal and illegal and explicitly including alcohol, poses some of the most prominent and perplexing issues facing modern societies. For nearly a century, the United States has been an active proponent of the punitive prohibition of illicit drugs. Unfortunately, the “War on Drugs” has been largely unsuccessful; prosecution of illegal drug consumption has filled our prisons without significantly reducing crime, decreasing homelessness, preventing overdose deaths.
William Martin, Ph.D., is the Harry and Hazel Chavanne Senior Fellow in Religion and Public Policy at the Baker Institute and the Chavanne Emeritus …
Read more about this expert
Katharine Neill Harris, Ph.D., is the Alfred C. Glassell, III, Fellow in Drug Policy at Rice University’s Baker Institute for Public Policy. Her current …
Read more about this expert
